OOIR: Observatory of International Research

Papers

(The H4-Index of Pediatric Blood & Cancer is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype	59
Brochure intervention to manage bothersome taste changes in pediatric patients receiving cancer therapy	52
Palliative care and suicidality: Complicated conversations at two ends of the spectrum	50
	46
Refractory thrombocytopenia and myelofibrosis in a novel KDSR mutation: Case report and literature review	42
Pediatric erythroblastic transformation of JAK2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations	41
Neonatal giant axillary hemangioma with subclavian arteriovenous fistula and heart failure	36
Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma	35
The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis	35
Bone mineral density in primarily preadolescent children with hemoglobin E/β‐thalassemia with different severities and transfusion requirements	33
Luspatercept for non‐deletional hemoglobin H disease	31
Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy	30
A three‐year‐old with central nervous system graft versus host disease: A rare cause of posthematopoietic stem cell transplant encephalopathy	29
Lactate dehydrogenase reflects the status of ultra‐high‐risk neuroblastoma in a child under treatment	27
Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma‐derived von Willebrand factor	26
How we approach complex vascular anomalies and overgrowth syndromes	25
Cabozantinib in children with recurrent diffuse gliomas	25
Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States	24
Efficacy of dual‐task training on stability and function in children with ataxia after medulloblastoma resection: A randomized controlled trial	24
Urgent Chemotherapy for Swift Symptom Relief in Patients With Medulloblastoma	24
Trametinib Monotherapy in the Treatment of Pediatric Refractory/Relapse Langerhans Cell Histiocytosis	23
	23
Shwachman–Diamond Syndrome Patient Progressing From Chronic Myelomonocytic Leukemia to Acute Myeloid Leukemia Within Two Months	23